JP2019536457A5 - - Google Patents

Download PDF

Info

Publication number
JP2019536457A5
JP2019536457A5 JP2019529204A JP2019529204A JP2019536457A5 JP 2019536457 A5 JP2019536457 A5 JP 2019536457A5 JP 2019529204 A JP2019529204 A JP 2019529204A JP 2019529204 A JP2019529204 A JP 2019529204A JP 2019536457 A5 JP2019536457 A5 JP 2019536457A5
Authority
JP
Japan
Prior art keywords
human
recombinant
cells
mouse
immunodeficient
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2019529204A
Other languages
English (en)
Japanese (ja)
Other versions
JP7458185B2 (ja
JP2019536457A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2017/063948 external-priority patent/WO2018102546A1/en
Publication of JP2019536457A publication Critical patent/JP2019536457A/ja
Publication of JP2019536457A5 publication Critical patent/JP2019536457A5/ja
Priority to JP2022166015A priority Critical patent/JP2023015064A/ja
Application granted granted Critical
Publication of JP7458185B2 publication Critical patent/JP7458185B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2019529204A 2016-11-30 2017-11-30 改善されたヒト自然免疫細胞の発生を有するヒト化マウスモデル Active JP7458185B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2022166015A JP2023015064A (ja) 2016-11-30 2022-10-17 改善されたヒト自然免疫細胞の発生を有するヒト化マウスモデル

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201662428131P 2016-11-30 2016-11-30
US62/428,131 2016-11-30
US201762565783P 2017-09-29 2017-09-29
US62/565,783 2017-09-29
PCT/US2017/063948 WO2018102546A1 (en) 2016-11-30 2017-11-30 Humanized mouse model with improved human innate immune cell development

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2022166015A Division JP2023015064A (ja) 2016-11-30 2022-10-17 改善されたヒト自然免疫細胞の発生を有するヒト化マウスモデル

Publications (3)

Publication Number Publication Date
JP2019536457A JP2019536457A (ja) 2019-12-19
JP2019536457A5 true JP2019536457A5 (cg-RX-API-DMAC7.html) 2021-01-21
JP7458185B2 JP7458185B2 (ja) 2024-03-29

Family

ID=60935945

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2019529204A Active JP7458185B2 (ja) 2016-11-30 2017-11-30 改善されたヒト自然免疫細胞の発生を有するヒト化マウスモデル
JP2022166015A Pending JP2023015064A (ja) 2016-11-30 2022-10-17 改善されたヒト自然免疫細胞の発生を有するヒト化マウスモデル

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2022166015A Pending JP2023015064A (ja) 2016-11-30 2022-10-17 改善されたヒト自然免疫細胞の発生を有するヒト化マウスモデル

Country Status (5)

Country Link
US (3) US20190320633A1 (cg-RX-API-DMAC7.html)
EP (1) EP3547831B1 (cg-RX-API-DMAC7.html)
JP (2) JP7458185B2 (cg-RX-API-DMAC7.html)
CN (1) CN110740641A (cg-RX-API-DMAC7.html)
WO (1) WO2018102546A1 (cg-RX-API-DMAC7.html)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018102546A1 (en) * 2016-11-30 2018-06-07 The Jackson Laboratory Humanized mouse model with improved human innate immune cell development
US11778994B2 (en) 2017-05-12 2023-10-10 The Jackson Laboratory NSG mice lacking MHC class I and class II
US11712026B2 (en) 2017-10-18 2023-08-01 The Jackson Laboratory Murine-MHC-deficient HLA-transgenic nod-mouse models for T1D therapy development
US20210355501A1 (en) * 2018-09-24 2021-11-18 Albert Einstein College Of Medicine Interleukin-8 for maintenance of human acute myeloid leukemia and myelodysplastic syndrome and uses thereof
US20220192166A1 (en) * 2019-03-28 2022-06-23 Central Institute For Experimental Animals Immunodeficient rodent
US20220312749A1 (en) * 2019-08-09 2022-10-06 Biocytogen Pharmaceuticals (Beijing) Co., Ltd. Genetically modified non-human animal with human or chimeric il2ra
CN111705082A (zh) * 2020-04-14 2020-09-25 澎立生物医药技术(上海)有限公司 具有髓系免疫细胞的人源化免疫系小鼠的构建方法
US20230270085A1 (en) * 2020-07-08 2023-08-31 The Jackson Laboratory Transgenic mouse model expressing human hla-a201 restriction gene
AU2021347320A1 (en) 2020-09-24 2023-05-11 The Jackson Laboratory Humanized mouse models for assessing immune cell therapy
CN114853871B (zh) * 2021-04-20 2024-04-05 百奥赛图(北京)医药科技股份有限公司 Csf1和/或csf1r基因人源化的非人动物及其构建方法和应用
CA3244028A1 (en) * 2021-12-22 2023-06-29 The Jackson Laboratory HUMANIZED WALL MODELS
JP2025525451A (ja) 2022-06-30 2025-08-05 ザ ユナイテッド ステイツ オブ アメリカ, アズ リプレゼンテッド バイ ザ セクレタリー, デパートメント オブ ヘルス アンド ヒューマン サービシーズ Cd25特異的抗体およびその使用
CN117070522A (zh) * 2022-08-15 2023-11-17 江苏集萃药康生物科技股份有限公司 一种细胞因子人源化的非人动物的制备方法及其应用
AU2023338373A1 (en) * 2022-09-08 2025-04-03 The Jackson Laboratory Humanized immunodeficient mouse models
US20260144239A1 (en) * 2022-10-25 2026-05-28 Lapix Therapeutics, Inc. Immune Cell-Engrafted Non-Human Animals and Non-Human Animal Models
WO2025041060A1 (en) * 2023-08-21 2025-02-27 VeraVerse Co., Ltd. Patient-derived xenograft model of cancer, preparation method thereof and an apparatus and a method for analyzing drug responsiveness using the same
WO2026001958A1 (zh) * 2024-06-24 2026-01-02 黄菁 Aav载体、aav载体的组合、构建aml pdx和mm pdx非人动物的方法及构建免疫系统人源化非人动物的方法
CN121891523A (zh) * 2026-03-24 2026-04-21 广东莱迪生物医药研究院有限公司 一种模拟肿瘤免疫微环境的双人源化小鼠模型及其应用

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1209968A1 (en) 1999-08-31 2002-06-05 Genencor International, Inc. Transgenic mammal capable of facilitating production of donor-specific functional immunity
EP1802193B1 (en) * 2004-10-19 2014-04-30 Regeneron Pharmaceuticals, Inc. Method for generating a mouse homozygous for a genetic modification
PT4233537T (pt) * 2011-02-15 2025-09-08 Regeneron Pharma Ratinhos humanizados para m-csf e utilizações dos mesmos
KR102241962B1 (ko) * 2012-09-07 2021-04-20 예일 유니버시티 유전적으로 변형된 비-인간 동물 및 이것들의 사용 방법
DK4389764T3 (da) * 2012-11-05 2026-04-13 Regeneron Pharma Genetisk modificerede gnavere og fremgangsmåder til anvendelse heraf
JP6492095B2 (ja) 2013-10-15 2019-03-27 リジェネロン・ファーマシューティカルズ・インコーポレイテッドRegeneron Pharmaceuticals, Inc. ヒト化il−15動物
US20150282460A1 (en) 2014-04-04 2015-10-08 Crown Bioscience Inc. (Taicang) Animal model with human immune system
EP3482629B1 (en) * 2014-05-19 2020-11-25 Regeneron Pharmaceuticals, Inc. Genetically modified non-human animals expressing human epo
ES2950399T3 (es) 2015-04-13 2023-10-09 Regeneron Pharma Ratones humanizados Sirpa-IL15 insertados y métodos de uso de los mismos
JP6654001B2 (ja) * 2015-05-27 2020-02-26 公益財団法人実験動物中央研究所 ヒトil−15分泌免疫不全マウス
TWI810145B (zh) * 2015-06-23 2023-08-01 杰克森實驗室 具有病患衍生之異種移植物之非hla配對的人源化nsg小鼠模式
AU2016343860A1 (en) 2015-10-30 2018-05-10 The Jackson Laboratory Compositions and methods relating to tumor analysis
AU2017348348A1 (en) 2016-10-27 2019-05-02 The Jackson Laboratory Genetically modified mouse model for human hepatocyte xenotransplantation
WO2018102546A1 (en) * 2016-11-30 2018-06-07 The Jackson Laboratory Humanized mouse model with improved human innate immune cell development
AU2018291497A1 (en) * 2017-06-30 2020-01-16 Xencor, Inc. Targeted heterodimeric Fc fusion proteins containing IL-15/IL-15Ra and antigen binding domains
IL272475B2 (en) 2017-08-09 2025-05-01 Jackson Lab Immunodeficient mice expressing interleukin 15
TWI838389B (zh) 2018-07-19 2024-04-11 美商再生元醫藥公司 雙特異性抗-BCMAx抗-CD3抗體及其用途
AU2019374055B2 (en) 2018-10-30 2026-06-11 Regeneron Pharmaceuticals, Inc. Methods for allogeneic hematopoietic stem cell transplantation

Similar Documents

Publication Publication Date Title
Mian et al. Advances in human immune system mouse models for studying human hematopoiesis and cancer immunotherapy
Hanazawa et al. Generation of human immunosuppressive myeloid cell populations in human interleukin-6 transgenic NOG mice
McCaughtry et al. Conditional deletion of cytokine receptor chains reveals that IL-7 and IL-15 specify CD8 cytotoxic lineage fate in the thymus
JP2022105531A (ja) 遺伝学的に修飾された非ヒト動物およびその使用法
EP3475413B1 (en) Genetically modified t lymphocytes
Delconte et al. NK cell priming from endogenous homeostatic signals is modulated by CIS
US20190167720A1 (en) Gene editing for immunological destruction of neoplasia
JP2012531896A5 (cg-RX-API-DMAC7.html)
Chou et al. Immunomodulatory effects of Saccharomyces cerevisiae fermentation product supplementation on immune gene expression and lymphocyte distribution in immune organs in broilers
US20220226379A1 (en) Dnmt3a knock-out stat5 activated genetically engineered t-cells
Stacey et al. IL-10 restricts activation-induced death of NK cells during acute murine cytomegalovirus infection
JP2020520367A5 (cg-RX-API-DMAC7.html)
Volk et al. Multidimensional analysis integrating human T-cell signatures in lymphatic tissues with sex of humanized mice for prediction of responses after dendritic cell immunization
US11725187B2 (en) Selection of human hematopoetic stem cells using EPCR
Li et al. Thymic selection pathway regulates the effector function of CD4 T cells
WO2017049002A1 (en) A humanized mouse model of de novo human acute myeloid leukemia with a matching human immune system
Prlic et al. Dissociating markers of senescence and protective ability in memory T cells
Ishikawa Modeling normal and malignant human hematopoiesis in vivo through newborn NSG xenotransplantation
Powell et al. SCID pigs: An emerging large animal NK model
CN111372449B (zh) 免疫缺陷小鼠
Panjwani et al. Single-cell profiling aligns CD56bright and cytomegalovirus-induced adaptive natural killer cells to a naïve-memory relationship
Mendoza-Valderrey et al. Next generation immuno-oncology strategies: unleashing NK cells activity
Chun et al. Engraftment of adult hematopoietic stem and progenitor cells in a novel model of humanized mice
Zheng et al. FLT3L combined with GM-CSF induced dendritic cells drive broad tumor-specific CD8+ T cell responses and remodel the tumor microenvironment to enhance anti-tumor efficacy
Pisano et al. Laboratory mice–A driving force in immunopathology and immunotherapy studies of human multiple myeloma